DNA double-strand break (DSB) repair is critical to prevent persistent DNA damage, counteract genome instability and suppress tumor development. By re-joining broken DNA ends, DSB repair has also the potential to produce chromosome translocations and complex rearrangements. In this project, we will investigate the mechanism and regulation of the earliest step of DSB repair, DNA end-processing and its impact on DSB repair choice, particularly microhomology-mediated end-joining (MMEJ). We hypothesize that persistent, short ssDNA overhangs is the aberrant DNA repair intermediate involved in MMEJ, the pathogenic form of DSB repair responsible for a significant fraction of tumorigenic chromosome translocations. First, we will delineate the conditions that favor the generation of these intennediates in cell-free extracts derived from Xenopus. We will evaluate the contribution of the three resection pathways: CtlP, EX01 and DN/^2. Next, we will assess the impact of cell cycle (CDK) and DNA damage (PIKK) protein kinases on these pathways and on DNA processing. Finally, we will evaluate how DNA resection influences MMEJ in human breast tumor cells with fully sequenced genomes and documented chromosome translocation landscapes. The biochemical findings gained from this project will inform experiments in all other projects of the program. The proposed experiments should provide an unprecedented level of understanding of the mechanism and regulation of resection of ligatable DNA ends as well as damaged DNA ends or DNA ends harboring adducts, such as those generated following chemo- or radiotherapy. In turn this will guide future studies aiming at decreasing the impact of chromosome translocations and improving the efficiency of cancer therapies based on the generation of DNA DSBs.

Public Health Relevance

Aberrant chromosome rearrangements, particulariy chromosome translocations, are implicated in the development of human cancers. Translocations often arise from a pathogenic form of DNA repair that generates short single-strand DNA intermediates with microhomologies (MH). The goal of this project is to determine how resection and the DNA repair protein, CtlP, participate in generating persistent, toxic repair intermediates with MH leading to chromosome translocations causing tumor development.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Program Projects (P01)
Project #
Application #
Study Section
Special Emphasis Panel ()
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Columbia University
New York
United States
Zip Code
Symington, Lorraine S (2016) Mechanism and regulation of DNA end resection in eukaryotes. Crit Rev Biochem Mol Biol 51:195-212
Yamamoto, Kenta; Wang, Jiguang; Sprinzen, Lisa et al. (2016) Kinase-dead ATM protein is highly oncogenic and can be preferentially targeted by Topo-isomerase I inhibitors. Elife 5:
Oh, Julyun; Al-Zain, Amr; Cannavo, Elda et al. (2016) Xrs2 Dependent and Independent Functions of the Mre11-Rad50 Complex. Mol Cell 64:405-415
Aparicio, Tomas; Baer, Richard; Gottesman, Max et al. (2016) MRN, CtIP, and BRCA1 mediate repair of topoisomerase II-DNA adducts. J Cell Biol 212:399-408
Reczek, Colleen R; Shakya, Reena; Miteva, Yana et al. (2016) The DNA resection protein CtIP promotes mammary tumorigenesis. Oncotarget 7:32172-83
Deng, Sarah K; Chen, Huan; Symington, Lorraine S (2015) Replication protein A prevents promiscuous annealing between short sequence homologies: Implications for genome integrity. Bioessays 37:305-13
Yamamoto, K; Lee, B J; Li, C et al. (2015) Early B-cell-specific inactivation of ATM synergizes with ectopic CyclinD1 expression to promote pre-germinal center B-cell lymphomas in mice. Leukemia 29:1414-24
Chen, Huan; Donnianni, Roberto A; Handa, Naofumi et al. (2015) Sae2 promotes DNA damage resistance by removing the Mre11-Rad50-Xrs2 complex from DNA and attenuating Rad53 signaling. Proc Natl Acad Sci U S A 112:E1880-7
Deng, Sarah K; Yin, Yi; Petes, Thomas D et al. (2015) Mre11-Sae2 and RPA Collaborate to Prevent Palindromic Gene Amplification. Mol Cell 60:500-8
Sato, Mai; Rodriguez-Barrueco, Ruth; Yu, Jiyang et al. (2015) MYC is a critical target of FBXW7. Oncotarget 6:3292-305

Showing the most recent 10 out of 14 publications